ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison.

Capodanno, Davide; Alfonso, Fernando; Levine, Glenn N; Valgimigli, Marco; Angiolillo, Dominick J (2018). ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison. Journal of the American College of Cardiology, 72(23 Pt A), pp. 2915-2931. Elsevier 10.1016/j.jacc.2018.09.057

[img] Text
1-s2.0-S0735109718387369-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (887kB) | Request a copy

Dual antiplatelet therapy (DAPT) is the cornerstone of pharmacological treatment aimed at preventing the atherothrombotic complications in patients with a variety of coronary artery disease (CAD) manifestations. Prescribers of DAPT are confronted with a number of challenges that include selecting the appropriate P2Y inhibitor and determining the optimal duration of DAPT with the scope of minimizing the risk of ischemic and bleeding complications in light of each patient's clinical characteristic and circumstance. Recently, a guideline writing committee from the American College of Cardiology/American Heart Association (ACC/AHA) and a task force from the European Society of Cardiology (ESC) released their respective focused update recommendations on "Duration of DAPT in Patients with CAD" (ACC/AHA) and "DAPT in CAD" (ESC). This paper aims to review the ACC/AHA and ESC updates for DAPT to delineate common domains, consistent messages, and differences in recommended management strategies across the Atlantic.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Valgimigli, Marco

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0735-1097

Publisher:

Elsevier

Language:

English

Submitter:

Amanda Valle

Date Deposited:

22 Feb 2019 12:47

Last Modified:

22 Feb 2019 12:47

Publisher DOI:

10.1016/j.jacc.2018.09.057

PubMed ID:

30522654

Uncontrolled Keywords:

antiplatelet bleeding stent thrombosis

BORIS DOI:

10.7892/boris.124013

URI:

https://boris.unibe.ch/id/eprint/124013

Actions (login required)

Edit item Edit item
Provide Feedback